Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hispanagar is a Spanish biotechnology company that stands as a global leader in the extraction and purification of seaweed-derived polysaccharides, particularly agar-agar and agarose. Founded in 1950 and headquartered in Burgos, the company provides high-quality raw materials essential for molecular biology, clinical diagnostics, and microbiology. Their product range includes specialized agarose for electrophoresis and chromatography, as well as a diverse portfolio of peptones and extracts used in the formulation of culture media. As a key subsidiary of the Zendal Group, Hispanagar serves the pharmaceutical and life sciences industries across more than 80 countries. The company maintains rigorous quality standards, including ISO 9001 and ISO 14001 certifications, ensuring the reliability of its products for sensitive laboratory applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hispanagar.